Hereditary Angioedema and Forecast Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hereditary Angioedema
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Segment by Type
1.2.2 Hereditary Angioedema Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hereditary Angioedema Market Overview
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Hereditary Angioedema Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hereditary Angioedema Market Competitive Landscape
3.1 Global Hereditary Angioedema Sales by Manufacturers (2019-2025)
3.2 Global Hereditary Angioedema Revenue Market Share by Manufacturers (2019-2025)
3.3 Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hereditary Angioedema Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Hereditary Angioedema Sales Sites, Area Served, Product Type
3.6 Hereditary Angioedema Market Competitive Situation and Trends
3.6.1 Hereditary Angioedema Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hereditary Angioedema Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hereditary Angioedema Industry Chain Analysis
4.1 Hereditary Angioedema Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hereditary Angioedema Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hereditary Angioedema Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Sales Market Share by Type (2019-2025)
6.3 Global Hereditary Angioedema Market Size Market Share by Type (2019-2025)
6.4 Global Hereditary Angioedema Price by Type (2019-2025)
7 Hereditary Angioedema Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Market Sales by Application (2019-2025)
7.3 Global Hereditary Angioedema Market Size (M USD) by Application (2019-2025)
7.4 Global Hereditary Angioedema Sales Growth Rate by Application (2019-2025)
8 Hereditary Angioedema Market Consumption by Region
8.1 Global Hereditary Angioedema Sales by Region
8.1.1 Global Hereditary Angioedema Sales by Region
8.1.2 Global Hereditary Angioedema Sales Market Share by Region
8.2 North America
8.2.1 North America Hereditary Angioedema Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hereditary Angioedema Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hereditary Angioedema Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hereditary Angioedema Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hereditary Angioedema Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Hereditary Angioedema Market Production by Region
9.1 Global Production of Hereditary Angioedema by Region (2019-2025)
9.2 Global Hereditary Angioedema Revenue Market Share by Region (2019-2025)
9.3 Global Hereditary Angioedema Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Hereditary Angioedema Production
9.4.1 North America Hereditary Angioedema Production Growth Rate (2019-2025)
9.4.2 North America Hereditary Angioedema Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Hereditary Angioedema Production
9.5.1 Europe Hereditary Angioedema Production Growth Rate (2019-2025)
9.5.2 Europe Hereditary Angioedema Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Hereditary Angioedema Production (2019-2025)
9.6.1 Japan Hereditary Angioedema Production Growth Rate (2019-2025)
9.6.2 Japan Hereditary Angioedema Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Hereditary Angioedema Production (2019-2025)
9.7.1 China Hereditary Angioedema Production Growth Rate (2019-2025)
9.7.2 China Hereditary Angioedema Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Pharming Group NV
10.1.1 Pharming Group NV Hereditary Angioedema Basic Information
10.1.2 Pharming Group NV Hereditary Angioedema Product Overview
10.1.3 Pharming Group NV Hereditary Angioedema Product Market Performance
10.1.4 Pharming Group NV Business Overview
10.1.5 Pharming Group NV Hereditary Angioedema SWOT Analysis
10.1.6 Pharming Group NV Recent Developments
10.2 Takeda
10.2.1 Takeda Hereditary Angioedema Basic Information
10.2.2 Takeda Hereditary Angioedema Product Overview
10.2.3 Takeda Hereditary Angioedema Product Market Performance
10.2.4 Takeda Business Overview
10.2.5 Takeda Hereditary Angioedema SWOT Analysis
10.2.6 Takeda Recent Developments
10.3 CSL Limited
10.3.1 CSL Limited Hereditary Angioedema Basic Information
10.3.2 CSL Limited Hereditary Angioedema Product Overview
10.3.3 CSL Limited Hereditary Angioedema Product Market Performance
10.3.4 CSL Limited Hereditary Angioedema SWOT Analysis
10.3.5 CSL Limited Business Overview
10.3.6 CSL Limited Recent Developments
10.4 iBio Inc.
10.4.1 iBio Inc. Hereditary Angioedema Basic Information
10.4.2 iBio Inc. Hereditary Angioedema Product Overview
10.4.3 iBio Inc. Hereditary Angioedema Product Market Performance
10.4.4 iBio Inc. Business Overview
10.4.5 iBio Inc. Recent Developments
10.5 BioCryst Pharmaceuticals
10.5.1 BioCryst Pharmaceuticals Hereditary Angioedema Basic Information
10.5.2 BioCryst Pharmaceuticals Hereditary Angioedema Product Overview
10.5.3 BioCryst Pharmaceuticals Hereditary Angioedema Product Market Performance
10.5.4 BioCryst Pharmaceuticals Business Overview
10.5.5 BioCryst Pharmaceuticals Recent Developments
10.6 Inc.
10.6.1 Inc. Hereditary Angioedema Basic Information
10.6.2 Inc. Hereditary Angioedema Product Overview
10.6.3 Inc. Hereditary Angioedema Product Market Performance
10.6.4 Inc. Business Overview
10.6.5 Inc. Recent Developments
10.7 Ionis Pharmaceuticals
10.7.1 Ionis Pharmaceuticals Hereditary Angioedema Basic Information
10.7.2 Ionis Pharmaceuticals Hereditary Angioedema Product Overview
10.7.3 Ionis Pharmaceuticals Hereditary Angioedema Product Market Performance
10.7.4 Ionis Pharmaceuticals Business Overview
10.7.5 Ionis Pharmaceuticals Recent Developments
10.8 Inc.
10.8.1 Inc. Hereditary Angioedema Basic Information
10.8.2 Inc. Hereditary Angioedema Product Overview
10.8.3 Inc. Hereditary Angioedema Product Market Performance
10.8.4 Inc. Business Overview
10.8.5 Inc. Recent Developments
11 Hereditary Angioedema Market Forecast by Region
11.1 Global Hereditary Angioedema Market Size Forecast
11.2 Global Hereditary Angioedema Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Hereditary Angioedema by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Hereditary Angioedema Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Hereditary Angioedema by Type (2025-2032)
12.1.2 Global Hereditary Angioedema Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Hereditary Angioedema by Type (2025-2032)
12.2 Global Hereditary Angioedema Market Forecast by Application (2025-2032)
12.2.1 Global Hereditary Angioedema Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Hereditary Angioedema Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Hereditary Angioedema Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Hereditary Angioedema Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2022)
Table 10. Global Market Hereditary Angioedema Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Hereditary Angioedema Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Product Type
Table 13. Global Hereditary Angioedema Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hereditary Angioedema
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Market Challenges
Table 22. Global Hereditary Angioedema Sales by Type (K MT)
Table 23. Global Hereditary Angioedema Market Size by Type (M USD)
Table 24. Global Hereditary Angioedema Sales (K MT) by Type (2019-2025)
Table 25. Global Hereditary Angioedema Sales Market Share by Type (2019-2025)
Table 26. Global Hereditary Angioedema Market Size (M USD) by Type (2019-2025)
Table 27. Global Hereditary Angioedema Market Size Share by Type (2019-2025)
Table 28. Global Hereditary Angioedema Price (USD/MT) by Type (2019-2025)
Table 29. Global Hereditary Angioedema Sales (K MT) by Application
Table 30. Global Hereditary Angioedema Market Size by Application
Table 31. Global Hereditary Angioedema Sales by Application (2019-2025) & (K MT)
Table 32. Global Hereditary Angioedema Sales Market Share by Application (2019-2025)
Table 33. Global Hereditary Angioedema Sales by Application (2019-2025) & (M USD)
Table 34. Global Hereditary Angioedema Market Share by Application (2019-2025)
Table 35. Global Hereditary Angioedema Sales Growth Rate by Application (2019-2025)
Table 36. Global Hereditary Angioedema Sales by Region (2019-2025) & (K MT)
Table 37. Global Hereditary Angioedema Sales Market Share by Region (2019-2025)
Table 38. North America Hereditary Angioedema Sales by Country (2019-2025) & (K MT)
Table 39. Europe Hereditary Angioedema Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Hereditary Angioedema Sales by Region (2019-2025) & (K MT)
Table 41. South America Hereditary Angioedema Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Hereditary Angioedema Sales by Region (2019-2025) & (K MT)
Table 43. Global Hereditary Angioedema Production (K MT) by Region (2019-2025)
Table 44. Global Hereditary Angioedema Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Hereditary Angioedema Revenue Market Share by Region (2019-2025)
Table 46. Global Hereditary Angioedema Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Hereditary Angioedema Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Hereditary Angioedema Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Hereditary Angioedema Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Hereditary Angioedema Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Pharming Group NV Hereditary Angioedema Basic Information
Table 52. Pharming Group NV Hereditary Angioedema Product Overview
Table 53. Pharming Group NV Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Pharming Group NV Business Overview
Table 55. Pharming Group NV Hereditary Angioedema SWOT Analysis
Table 56. Pharming Group NV Recent Developments
Table 57. Takeda Hereditary Angioedema Basic Information
Table 58. Takeda Hereditary Angioedema Product Overview
Table 59. Takeda Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Takeda Business Overview
Table 61. Takeda Hereditary Angioedema SWOT Analysis
Table 62. Takeda Recent Developments
Table 63. CSL Limited Hereditary Angioedema Basic Information
Table 64. CSL Limited Hereditary Angioedema Product Overview
Table 65. CSL Limited Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. CSL Limited Hereditary Angioedema SWOT Analysis
Table 67. CSL Limited Business Overview
Table 68. CSL Limited Recent Developments
Table 69. iBio Inc. Hereditary Angioedema Basic Information
Table 70. iBio Inc. Hereditary Angioedema Product Overview
Table 71. iBio Inc. Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. iBio Inc. Business Overview
Table 73. iBio Inc. Recent Developments
Table 74. BioCryst Pharmaceuticals Hereditary Angioedema Basic Information
Table 75. BioCryst Pharmaceuticals Hereditary Angioedema Product Overview
Table 76. BioCryst Pharmaceuticals Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. BioCryst Pharmaceuticals Business Overview
Table 78. BioCryst Pharmaceuticals Recent Developments
Table 79. Inc. Hereditary Angioedema Basic Information
Table 80. Inc. Hereditary Angioedema Product Overview
Table 81. Inc. Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Inc. Business Overview
Table 83. Inc. Recent Developments
Table 84. Ionis Pharmaceuticals Hereditary Angioedema Basic Information
Table 85. Ionis Pharmaceuticals Hereditary Angioedema Product Overview
Table 86. Ionis Pharmaceuticals Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Ionis Pharmaceuticals Business Overview
Table 88. Ionis Pharmaceuticals Recent Developments
Table 89. Inc. Hereditary Angioedema Basic Information
Table 90. Inc. Hereditary Angioedema Product Overview
Table 91. Inc. Hereditary Angioedema Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Inc. Business Overview
Table 93. Inc. Recent Developments
Table 94. Global Hereditary Angioedema Sales Forecast by Region (2025-2032) & (K MT)
Table 95. Global Hereditary Angioedema Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Hereditary Angioedema Sales Forecast by Country (2025-2032) & (K MT)
Table 97. North America Hereditary Angioedema Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Hereditary Angioedema Sales Forecast by Country (2025-2032) & (K MT)
Table 99. Europe Hereditary Angioedema Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Hereditary Angioedema Sales Forecast by Region (2025-2032) & (K MT)
Table 101. Asia Pacific Hereditary Angioedema Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Hereditary Angioedema Sales Forecast by Country (2025-2032) & (K MT)
Table 103. South America Hereditary Angioedema Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Hereditary Angioedema Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Hereditary Angioedema Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Hereditary Angioedema Sales Forecast by Type (2025-2032) & (K MT)
Table 107. Global Hereditary Angioedema Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Hereditary Angioedema Price Forecast by Type (2025-2032) & (USD/MT)
Table 109. Global Hereditary Angioedema Sales (K MT) Forecast by Application (2025-2032)
Table 110. Global Hereditary Angioedema Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Hereditary Angioedema
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Market Size (M USD), 2019-2032
Figure 5. Global Hereditary Angioedema Market Size (M USD) (2019-2032)
Figure 6. Global Hereditary Angioedema Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Market Size by Country (M USD)
Figure 11. Hereditary Angioedema Sales Share by Manufacturers in 2023
Figure 12. Global Hereditary Angioedema Revenue Share by Manufacturers in 2023
Figure 13. Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hereditary Angioedema Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hereditary Angioedema Market Share by Type
Figure 18. Sales Market Share of Hereditary Angioedema by Type (2019-2025)
Figure 19. Sales Market Share of Hereditary Angioedema by Type in 2023
Figure 20. Market Size Share of Hereditary Angioedema by Type (2019-2025)
Figure 21. Market Size Market Share of Hereditary Angioedema by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hereditary Angioedema Market Share by Application
Figure 24. Global Hereditary Angioedema Sales Market Share by Application (2019-2025)
Figure 25. Global Hereditary Angioedema Sales Market Share by Application in 2023
Figure 26. Global Hereditary Angioedema Market Share by Application (2019-2025)
Figure 27. Global Hereditary Angioedema Market Share by Application in 2023
Figure 28. Global Hereditary Angioedema Sales Growth Rate by Application (2019-2025)
Figure 29. Global Hereditary Angioedema Sales Market Share by Region (2019-2025)
Figure 30. North America Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Hereditary Angioedema Sales Market Share by Country in 2023
Figure 32. U.S. Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Hereditary Angioedema Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Hereditary Angioedema Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Hereditary Angioedema Sales Market Share by Country in 2023
Figure 37. Germany Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Hereditary Angioedema Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Hereditary Angioedema Sales Market Share by Region in 2023
Figure 44. China Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Hereditary Angioedema Sales and Growth Rate (K MT)
Figure 50. South America Hereditary Angioedema Sales Market Share by Country in 2023
Figure 51. Brazil Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Hereditary Angioedema Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Hereditary Angioedema Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Hereditary Angioedema Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Hereditary Angioedema Production Market Share by Region (2019-2025)
Figure 62. North America Hereditary Angioedema Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Hereditary Angioedema Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Hereditary Angioedema Production (K MT) Growth Rate (2019-2025)
Figure 65. China Hereditary Angioedema Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Hereditary Angioedema Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Hereditary Angioedema Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Hereditary Angioedema Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Hereditary Angioedema Market Share Forecast by Type (2025-2032)
Figure 70. Global Hereditary Angioedema Sales Forecast by Application (2025-2032)
Figure 71. Global Hereditary Angioedema Market Share Forecast by Application (2025-2032)
Industry Market Size
